Lenskart vs Titan: 7 factors defining India's Rs 30,000-crore eyewear battle post-IPO
Post-listing at Rs 390 (below Rs 402 issue price), Lenskart's vertical model — in-house manufacturing, 35-40% cost edge, 69.2% Q2 product margin and next-day delivery in 58 cities — squares off against Titan EyeCare's 871-store prescription-led omnichannel play. Titan holds <12% share; Lenskart posted Rs 2,146.6 crore Q2 revenue, up 24% YoY.
Post-Lenskart IPO comparison of India's two eyewear leaders across store reach, business models, margins and manufacturing. Lenskart leans on in-house production and fast delivery; Titan EyeCare on prescription-led optometry and omnichannel transition.
Why this matters
The IPO-battle framing follows HSBC's 'Hold' rating on Lenskart with a Rs 513 target, flagging rich valuation despite a 7,000-store expansion runway now tested against Titan's omnichannel scale.
Retail-company signals are accelerating, up 517900% QoQ.